Sign in
Taking people in United StatesPhase 1

Donor stem cells from umbilical cord or placenta for osteoarthritis

Tests the safety of donor stem cells in people with osteoarthritis.

Key facts

Who runs it
The Foundation for Orthopaedics and Regenerative Medicine
Where
Naples, United StatesSee the siteAlso in 1 other country, 1 site
Trial code
Registry title
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for OA
Status
Recruiting
Phase
Phase 1
People taking part
92 people, planned
Started
1 Dec 2022
Expected to end
1 Dec 2027
Type of study
Interventional
Treatments tested
  • AlloRx
Record updated
16 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with osteoarthritis. It tests the safety of donor stem cells from umbilical cord or placenta, given into a vein and into the joint.

Sex
All sexes can join.
Disease stage
A diagnosis of osteoarthritis.
Earlier treatment
People who had an organ transplant before cannot join.

Main reasons for not taking part

  • Active infection or active cancer
  • Long-term failure of several organs
  • Pregnancy, or women before menopause not using birth control
  • Important abnormal results on lab tests before treatment
  • Ongoing drug abuse or allergy to sulfur

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Diagnosis of Osteoarthritis
  • Understanding and willingness to sign a written informed consent document

Who cannot take part

  • Continued drug abuse
  • Previous organ transplant
  • Active infection
  • Active cancer
  • Chronic multisystem organ failure
  • Medical condition that would (based on the opinion of the investigator) compromise patient's safety
  • Hypersensitivity to sulfur
  • Clinically significant Abnormalities on pre-treatment laboratory evaluation
  • Pregnancy
  • Pre-menopausal women not using contraception

Where in United States

Also in 1 other country, 1 site

  • Prodromos Stem Cell InstituteNaples, United StatesContact: Chadwick Prodromos, MDTaking people

About the trial

What the trial wants to find out

This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells delivered intravenously and intraarticularly for the treatment of Osteoarthritis.

The group in the trial

  • Treatment Group (AlloRx)Treatment being tested

    Intravenous infusion and intraarticular injection (total dose of 100 million cells)

    Treatment: AlloRx

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for the Treatment of Osteoarthritis
Plain-language title
Donor stem cells from umbilical cord or placenta for osteoarthritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
16 October 2026